期刊文献+

CRISPR技术的发展及应用研究进展 被引量:6

Research Progresses on the Development and Application of CRISPR Technology
下载PDF
导出
摘要 CRISPR作为一种基于RNA的后天免疫防御系统,其间隔序列与噬菌体或质粒序列存在同源性,能利用靶位点特异性的RNA指导Cas蛋白靶向几乎所有生物和细胞中遗传错误的基因。与锌指核酶ZFN和转录激活因子样效应物核酶TALEN的基因编辑技术相比,更廉价高效,所以自2013年首次应用以来,迅速被广大中外研究人员接受并应用于研究,成为当今生命科学领域研究的新热点。鉴于CRISPR对今后的科学研究及现实应用具有重要意义,对CRISPR研究的最新动态及在基因治疗等方面的应用进行综述,并在此基础上讨论了该技术存在的局限性及解决方法,最后对CRISPR的研究前景进行了展望,以期为相关科研人员了解CRISPR提供参考。 CRISPR,an adaptive immune defense system based on RNA,whose space sequence has homologous with the sequences of phage or plasmid,can use RNA that has specificity in target point to guide the Cas proteins to target the genetic error genes in almost allorganisms and cells. This gene editing technique,compared with zinc finger nuclease(ZFN)and transcription activator-like effector nuclease(TALEN),is cheaper and more efficient. Therefore,since its first application in 2013,CRISPR has been accepted quickly and applied tothe studies by the masses of Chinese and foreign researchers,becoming a new hot spot in today's life science research. Regarding the greatsignificance of CRISPR in future scientific studies and practical applications,this article reviews the recent research progress on CRISPRand its applications in gene therapy,and discusses the limitations of this technology and the solutions. Finally,the foreground of CRISPR is prospected for providing useful reference for relevant researchers.
作者 梁丽琴 阎婧 张鑫 郝泽婷 段江燕 LIANG Li-qin;YAN Jing ZHANG;Xin HAO Ze-ting;DUAN Jiang-yan(Life Science College, Shanxi Normal University, Linfen 041004)
出处 《生物技术通报》 CAS CSCD 北大核心 2018年第5期9-16,共8页 Biotechnology Bulletin
基金 2015年山西省青年科技研究基金面上项目(2015021137)
关键词 CRISPR Cas蛋白 基因治疗 CRISPR Cas protein gene therapy
  • 相关文献

参考文献4

二级参考文献23

  • 1Joung JK, Sander JD. TALENs: a widely applicable technol-ogy for targeted genome editing. Nat Rev Mol Cell Biol 2012;14:49-55.
  • 2Moehle EA, Rock JM, Lee YL, et al. Targeted gene addi-tion into a specified location in the human genome using de-signed zinc fingernucleases. Proc Natl Acad Sci USA 2007;104:3055-3060.
  • 3Umov FD, Miller JC,Lee YL, et al Highly efficient endoge-nous human gene correction using designed zinc-finger nucle-ases. Nature 2005;435:646-651.
  • 4Hockemeyer D, Wang H,Kiani S, et al Genetic engineering ofhuman pluripotent cells using TALE nucleases. Nat Biotechnol2011;29:731-734.
  • 5Miller JC, Tan S, Qiao G, et al A TALE nuclease architecturefor efficient genome editing. Nat Biotechnol 2011; 29:143-148.
  • 6Chen F, Pruett-Miller SM, Huang Y,et al. High-frequency ge-nome editing using ssDNA oligonucleotides with zinc-fingernucleases. Nat Methods 2011; 8:753-755.
  • 7Bedell VM, Wang Y,Campbell JM, et al. In vivo genomeediting using a high-efficiency TALEN system. Nature 2012;491:114-118.
  • 8Makarova KS,Haft DH,Barrangou R, et al Evolution andclassification of the CRISPR-Cas systems. Nat Rev Microbiol2011;9:467-477.
  • 9Haurwitz RE, Jinek M,Wiedenheft B,Zhou K,Doudna JA.Sequence- and structure-specific RNA processing by a CRIS-PR endonuclease. Science 2010; 329:1355-1358.
  • 10Deltcheva E,Chylinski K,Sharma CM, et al. CRISPR RNAmaturation by trans-encoded small RNA and host factor RNaseIII. Nature 2011; 471:602-607.

共引文献331

同被引文献44

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部